Limits...
Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.

Obara T, Abe S, Satoh M, GutiƩrrez Ubeda SR, Yoshimachi S, Goto T - Pharmgenomics Pers Med (2015)

Bottom Line: Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine.Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]).We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacy, Tohoku University Hospital, Sendai, Japan ; Division of Molecular Epidemiology, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Japan ; Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

ABSTRACT
Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine. Therefore, pharmacists will soon have to provide guidance and raise pharmaceutical questions regarding prescriptions based on patient pharmacogenomic information. The objective of this study was to clarify Japanese pharmacists' awareness of pharmacogenetics. We conducted a postal questionnaire survey among 372 pharmacists belonging to Tsuruha Holdings. Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]). Of the pharmacists, 19.0% of the population were aware of the Ethical Guidelines for Human Genome/ Gene Analysis Research in Japan, 31.0% of the population had heard either or both the terms "pharmacogenomics" and "pharmacogenetics", and 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Only 0.4% indicated that they could raise pharmaceutical questions regarding prescriptions based on patients' pharmacogenomic information, and 61.2% of the population indicated a preference to undertake pharmacogenomic tests to predict the efficacy or adverse reactions of a drug. We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

No MeSH data available.


Personal preference with regard to undergoing pharmacogenomic tests for own medication.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4325628&req=5

f5-pgpm-8-035: Personal preference with regard to undergoing pharmacogenomic tests for own medication.

Mentions: When asked about personal preferences to undertake pharmacogenomic tests able to predict the efficacy or adverse reactions of a drug based on available pharmacogenomic information, 61.2% of the population indicated a preference to undertake pharmacogenomic tests, 11.9% indicated a preference not to undertake pharmacogenomic tests, and 26.9% indicated they were unsure. A higher proportion of women indicated they were unsure, and a higher proportion of pharmacists younger than 40 years of age indicated a preference to undertake pharmacogenomic tests (Figure 5).


Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.

Obara T, Abe S, Satoh M, GutiƩrrez Ubeda SR, Yoshimachi S, Goto T - Pharmgenomics Pers Med (2015)

Personal preference with regard to undergoing pharmacogenomic tests for own medication.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4325628&req=5

f5-pgpm-8-035: Personal preference with regard to undergoing pharmacogenomic tests for own medication.
Mentions: When asked about personal preferences to undertake pharmacogenomic tests able to predict the efficacy or adverse reactions of a drug based on available pharmacogenomic information, 61.2% of the population indicated a preference to undertake pharmacogenomic tests, 11.9% indicated a preference not to undertake pharmacogenomic tests, and 26.9% indicated they were unsure. A higher proportion of women indicated they were unsure, and a higher proportion of pharmacists younger than 40 years of age indicated a preference to undertake pharmacogenomic tests (Figure 5).

Bottom Line: Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine.Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]).We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacy, Tohoku University Hospital, Sendai, Japan ; Division of Molecular Epidemiology, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Japan ; Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

ABSTRACT
Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine. Therefore, pharmacists will soon have to provide guidance and raise pharmaceutical questions regarding prescriptions based on patient pharmacogenomic information. The objective of this study was to clarify Japanese pharmacists' awareness of pharmacogenetics. We conducted a postal questionnaire survey among 372 pharmacists belonging to Tsuruha Holdings. Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]). Of the pharmacists, 19.0% of the population were aware of the Ethical Guidelines for Human Genome/ Gene Analysis Research in Japan, 31.0% of the population had heard either or both the terms "pharmacogenomics" and "pharmacogenetics", and 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Only 0.4% indicated that they could raise pharmaceutical questions regarding prescriptions based on patients' pharmacogenomic information, and 61.2% of the population indicated a preference to undertake pharmacogenomic tests to predict the efficacy or adverse reactions of a drug. We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

No MeSH data available.